source
- Moderna reports Q1 revenue surge driven by international COVID vaccine sales despite larger net lossModerna posted first‑quarter revenue of $389 million, more than triple the same period a year earlier, primarily from overseas COVID‑19 vaccine sales. The company recorded a net loss of $1.3 billi…
- Eli Lilly beats forecasts with 56% revenue jump, lifts full-year outlookEli Lilly reported first‑quarter revenue of $19.8 billion, up 56% year over year, and net income of $7.4 billion, or $8.26 a share. Non‑GAAP earnings were $8.55 a share, well above the $6.77 consen…